Noor Ul Ain Rehman
Sat, January 10, 2026 astatine 1:57 PM CST 2 min read
The presumption of the statement entail that Eli Lilly and Company (NYSE:LLY) would get each the outstanding shares of Ventyx for $14.00 per stock of communal banal successful an all-cash transaction, which equals an aggregate equity worth of astir $1.2 billion. Expected to adjacent successful H1 2026, the transaction is not taxable to immoderate financing condition, and is taxable to support of Ventyx stockholders and restitution of different customary closing conditions, which see regulatory approvals.
Eli Lilly and Company (NYSE:LLY) further reported that the transaction gained support from the boards of directors of some companies, and that the acquisition terms payable astatine closing represents a premium of astir 62% to the 30-day volume-weighted mean trading terms of Ventyx’s communal banal ended connected January 5, 2026.
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and different therapies.
While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

2 days ago
1






English (CA) ·
English (US) ·
Spanish (MX) ·